PROJECT JEET – Joint Effort for Elimination of Tuberculosis

Project JEET is being jointly implemented by William J. Clinton Foundation (WJCF), Centre for Health Research & Innovation (CHRI) and Foundation for Innovative New Diagnostics (FIND), and funded by Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM)

OBJECTIVES

The key objective of this project is to set up effective and sustainable structures to strengthen existing systems and seamlessly extend quality TB care to patients in the private sector.

The project takes a multi-pronged approach to engaging with the private sector, as part of the NSP mantra of “go where the patients go”.

Building upon the joint successes and learnings of partner organizations in the consortium, the project is designed to address inefficiencies at every step of the patient care cascade. The project takes a multi-pronged approach to engaging with the private sector, as part of the NSP mantra of “go where the patients go”.

The project proposes to contract agencies at the district level to work closely with the patient and all patient touchpoints, including chemists, pharmacies, clinics, providers, hospitals, laboratories, and RNTCP. The project will engage with the RNTCP network at national, state and district levels.

JEET CONSORTIUM

William J. Clinton Foundation (WJCF) in India, working closely with Clinton Health Access Initiative (CHAI) is a global health organization committed to strengthening integrated health systems in the developing world and expanding access to care and treatment for HIV/AIDS, malaria and tuberculosis.

clintonhealthaccess.org

FIND seeks to ensure equitable access to reliable diagnosis around the world. We connect countries and communities, funders, decision-makers, healthcare providers and developers to spur diagnostic innovation and make testing an integral part of sustainable, resilient health systems. We are co-convener of the Access to COVID-19 Tools (ACT) Accelerator diagnostics pillar, and a WHO Collaborating Centre for Laboratory Strengthening and Diagnostic Technology Evaluation. Established in Geneva, Switzerland, in 2003, we have regional hubs in Kenya, India, South Africa and Viet Nam. Our office in India opened in 2007, and today we are the only India-registered non-profit organization solely devoted to improving diagnostic testing. With partners across the public and private sectors, we are working to make sure that everyone who needs a test can get one.

finddx.org

Centre for Health Research & Innovation (CHRI), a PATH affiliate, aims to create public health impact in India. CHRI seeks to drive innovation in health systems and services of India to benefit the poorest and most vulnerable through a collaborative approach.

chri.org.in

JEET SERVICES

MISSION 2025

The World Health Organization (WHO) End TB Strategy was endorsed by the World Health Assembly in May 2014, and has the ambitious goal of ending the global tuberculosis (TB) epidemic by 2030.

In tandem with the WHO goals, India has set an aggressive target of eliminating tuberculosis by 2025.